Drug and Therapeutics Bulletin 1996;34:41-45; doi:10.1136/dtb.1996.34641
Copyright © 1996 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

The antiarrhythmic treatment of atrial fibrillation

In this article we review antiarrhythmic treatment for patients with atrial fibrillation (AF). Two years ago we discussed the role of warfarin or aspirin for the prevention of thromboembolic complications of AF.1 Here we consider the drugs used to restore and maintain sinus rhythm, to prevent paroxysmal episodes and to control the ventricular rate in paroxysmal or persistent AF. We also consider briefly the place of rhythm control using electrical means.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1996 BMJ Publishing Group Ltd.